Rationale, design and organisation of an efficacy and safety study of oxypurinol added to standard therapy in patients with NYHA class III – IV congestive heart failure

Author： Freudenberger Ronald S   Schwarz Jr Richard P   Brown Joanne   Moore Alan   Mann Douglas   Givertz Michael M   Colucci Wilson S   Hare Joshua M  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.13, Iss.11, 2004-11, pp. : 1509-1516

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rationale for the Use of Aldosterone Antagonists in Congestive Heart Failure

By Rocha R.  

Drugs, Vol. 62, Iss. 5, 2002-01 ,pp. : 723-731

Adis International

Access to resources Recommend Favorite

Rationale and Design of a Randomized, Double-Blind, Placebo Controlled Multicenter Trial to Study Efficacy, Security, and Long Term Effects of Intermittent Repeated Levosimendan Administration in Patients with Advanced Heart Failure: LAICA study

By García-González Martín   Mora-Martín Manuel   López-Fernández Silvia   López-Díaz Javier   Martínez-Sellés Manuel   Romero-García José   Cordero Marco   Lara-Padrón Antonio   Marrero-Rodríguez Francisco   Mar García-Saiz M.   Aldea-Perona Ana  

Cardiovascular Drugs and Therapy, Vol. 27, Iss. 6, 2013-12 ,pp. : 573-579

Springer Publishing Company

Access to resources Recommend Favorite

Rationale and Design of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) Study

By  

Heart Drug, Vol. 2, Iss. 4, 2002-11 ,pp. : 164-166

Karger

Access to resources Recommend Favorite

Allopurinol or Oxypurinol in Heart Failure Therapy – a Promising New Development or End of Story?

By Reyes Ariel   Leary William  

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 5, 2005-10 ,pp. : 311-313

Springer Publishing Company

Access to resources Recommend Favorite

Intravenous Vasodilator Therapy in Congestive Heart Failure

By Moazemi K.   Chana J.S.   Willard A.M.   Kocheril A.G.  

Drugs & Aging, Vol. 20, Iss. 7, 2003-01 ,pp. : 485-508

Adis International

Access to resources Recommend Favorite